Andrew C. currently serves as General Partner at PPD since February 2025, bringing extensive experience in various leadership roles within the life sciences and healthcare sectors. Prior to PPD, Andrew held the position of Chief Commercial Officer at Caidya and served as Chief Business Development Officer at Biotaspheric Ltd, where involvement was pro-bono, focusing on innovative anti-infectives. Andrew's previous positions include Chief Executive Officer at Optimapharm and Swedish Biomimetics 3000 μLOT Technology, as well as significant roles at TFS HealthScience, Julius Clinical, Parexel, ICON plc, and Covance. Andrew holds a PhD in Respiratory & Exercise Physiology from Loughborough University obtained between 1991 and 1994.
This person is not in the org chart
This person is not in any teams
This person is not in any offices